FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313406250> ?p ?o ?g. }

• W4313406250 endingPage "64" @default.
• W4313406250 startingPage "64" @default.
• W4313406250 abstract "<ns3:p><ns3:bold>Background:</ns3:bold> Chest physiotherapy is an established cornerstone of care for people with cystic fibrosis (pwCF), but is often burdensome. Guidelines recommend at least one chest physiotherapy session daily, using various airway clearance techniques (ACTs). Exercise (with huffs and coughs) may offer an alternative ACT, however the willingness of pwCF to be randomised into a trial needs testing. The ‘ExACT-CF: Exercise as an Airway Clearance Technique in people with Cystic Fibrosis’ trial will test the feasibility of recruiting pwCF to be randomised to continue usual care (chest physiotherapy) or replace it with exercise ACT (ExACT) for 28-days. Secondary aims include determining the short-term clinical impact (and safety) of stopping routine chest physiotherapy and replacing it with ExACT, and effects on physical activity, sleep, mood, quality of life and treatment burden, alongside preliminary health economic measures and acceptability.</ns3:p><ns3:p> <ns3:bold>Methods:</ns3:bold> Multi-centre, two-arm, randomised (1:1 allocation using minimisation), pilot trial at two sites. Fifty pwCF (≥10 years, FEV<ns3:sub>1</ns3:sub> >40% predicted, stable on Elexacaftor/Tezacaftor/Ivacaftor (ETI)) will be randomised to an individually-customised ExACT programme (≥once daily aerobic exercise of ≥20-minutes duration at an intensity that elicits deep breathing, with huffs and coughs), or usual care. After baseline assessments, secondary outcomes will be assessed after 28-days, with additional home lung function and exacerbation questionnaires at 7, 14 and 21-days, physical activity and sleep monitoring throughout, and embedded qualitative and health-economic components. Feasibility measures include recruitment, retention, measurement completion, adverse events, interviews exploring the acceptability of trial procedures, and a trial satisfaction questionnaire.</ns3:p><ns3:p> <ns3:bold>Discussion:</ns3:bold> Co-designed with the UK CF community, the ExACT-CF pilot trial is the first multi-centre RCT to test the feasibility of recruiting pwCF stable on ETI into a trial investigating ExACT. This pilot trial will inform the feasibility, design, management, likely external validity for progression to a main phase randomised controlled trial.</ns3:p><ns3:p> <ns3:bold>Registration:</ns3:bold> Clinicaltrials.gov (<ns3:ext-link xmlns:ns4=http://www.w3.org/1999/xlink ext-link-type=uri ns4:href=https://clinicaltrials.gov/ct2/show/NCT05482048?term=NCT05482048&draw=2&rank=1>NCT05482048</ns3:ext-link>).</ns3:p>" @default.
• W4313406250 created "2023-01-06" @default.
• W4313406250 creator A5002655540 @default.
• W4313406250 creator A5012816963 @default.
• W4313406250 creator A5015926363 @default.
• W4313406250 creator A5023756609 @default.
• W4313406250 creator A5035667631 @default.
• W4313406250 creator A5056023987 @default.
• W4313406250 creator A5058627078 @default.
• W4313406250 creator A5063610744 @default.
• W4313406250 creator A5068236105 @default.
• W4313406250 creator A5071385206 @default.
• W4313406250 date "2022-12-19" @default.
• W4313406250 modified "2023-09-27" @default.
• W4313406250 title "Exercise as an Airway Clearance Technique in people with Cystic Fibrosis (ExACT-CF): rationale and study protocol for a randomised pilot trial" @default.
• W4313406250 cites W1976264709 @default.
• W4313406250 cites W1990166011 @default.
• W4313406250 cites W2070075051 @default.
• W4313406250 cites W2071031373 @default.
• W4313406250 cites W2073102812 @default.
• W4313406250 cites W2112620046 @default.
• W4313406250 cites W2123491496 @default.
• W4313406250 cites W2131217000 @default.
• W4313406250 cites W2131236190 @default.
• W4313406250 cites W2145555293 @default.
• W4313406250 cites W2146363913 @default.
• W4313406250 cites W2150238045 @default.
• W4313406250 cites W2150412459 @default.
• W4313406250 cites W2166023752 @default.
• W4313406250 cites W2171811563 @default.
• W4313406250 cites W2313223576 @default.
• W4313406250 cites W2346199818 @default.
• W4313406250 cites W2414339359 @default.
• W4313406250 cites W2588182016 @default.
• W4313406250 cites W2737761178 @default.
• W4313406250 cites W2754849847 @default.
• W4313406250 cites W2757092266 @default.
• W4313406250 cites W2883219276 @default.
• W4313406250 cites W2885816792 @default.
• W4313406250 cites W2896643754 @default.
• W4313406250 cites W2904188712 @default.
• W4313406250 cites W2948539979 @default.
• W4313406250 cites W2982296199 @default.
• W4313406250 cites W2985122258 @default.
• W4313406250 cites W2985405196 @default.
• W4313406250 cites W2985977936 @default.
• W4313406250 cites W2991309768 @default.
• W4313406250 cites W3113934310 @default.
• W4313406250 cites W3130951390 @default.
• W4313406250 cites W3157211386 @default.
• W4313406250 cites W3207295126 @default.
• W4313406250 cites W3208534440 @default.
• W4313406250 cites W3212372013 @default.
• W4313406250 cites W4214721068 @default.
• W4313406250 cites W4225726233 @default.
• W4313406250 cites W4232911575 @default.
• W4313406250 cites W4240531860 @default.
• W4313406250 cites W4283259239 @default.
• W4313406250 cites W4294732535 @default.
• W4313406250 cites W4296231772 @default.
• W4313406250 cites W4298109461 @default.
• W4313406250 cites W4303446509 @default.
• W4313406250 doi "https://doi.org/10.3310/nihropenres.13347.1" @default.
• W4313406250 hasPublicationYear "2022" @default.
• W4313406250 type Work @default.
• W4313406250 citedByCount "0" @default.
• W4313406250 crossrefType "journal-article" @default.
• W4313406250 hasAuthorship W4313406250A5002655540 @default.
• W4313406250 hasAuthorship W4313406250A5012816963 @default.
• W4313406250 hasAuthorship W4313406250A5015926363 @default.
• W4313406250 hasAuthorship W4313406250A5023756609 @default.
• W4313406250 hasAuthorship W4313406250A5035667631 @default.
• W4313406250 hasAuthorship W4313406250A5056023987 @default.
• W4313406250 hasAuthorship W4313406250A5058627078 @default.
• W4313406250 hasAuthorship W4313406250A5063610744 @default.
• W4313406250 hasAuthorship W4313406250A5068236105 @default.
• W4313406250 hasAuthorship W4313406250A5071385206 @default.
• W4313406250 hasBestOaLocation W43134062501 @default.
• W4313406250 hasConcept C118552586 @default.
• W4313406250 hasConcept C126322002 @default.
• W4313406250 hasConcept C159110408 @default.
• W4313406250 hasConcept C168563851 @default.
• W4313406250 hasConcept C1862650 @default.
• W4313406250 hasConcept C2776705957 @default.
• W4313406250 hasConcept C2776938444 @default.
• W4313406250 hasConcept C2777014857 @default.
• W4313406250 hasConcept C2779951463 @default.
• W4313406250 hasConcept C2780733359 @default.
• W4313406250 hasConcept C71924100 @default.
• W4313406250 hasConceptScore W4313406250C118552586 @default.
• W4313406250 hasConceptScore W4313406250C126322002 @default.
• W4313406250 hasConceptScore W4313406250C159110408 @default.
• W4313406250 hasConceptScore W4313406250C168563851 @default.
• W4313406250 hasConceptScore W4313406250C1862650 @default.
• W4313406250 hasConceptScore W4313406250C2776705957 @default.
• W4313406250 hasConceptScore W4313406250C2776938444 @default.
• W4313406250 hasConceptScore W4313406250C2777014857 @default.
• W4313406250 hasConceptScore W4313406250C2779951463 @default.

• next